Skip to content

Cesarean Scar Pregnancy and Clinical Outcomes

Clinical Outcomes of Cesarean Scar Pregnancy With Different Type: a Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05481606
Enrollment
500
Registered
2022-08-01
Start date
2022-08-01
Completion date
2025-08-01
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Blood Loss, Hysterectomy, Maternal Transmission, Placenta Accreta Spectrum, Repeat Cesarean Section

Brief summary

This study is a prospective cohort study, led by Prof. Zhao Yangyu, from the Department of Gynecology & Obstetrics, Peking University Third Hospital.

Detailed description

Cesarean section, myomectomy and other surgeries for uterus are likely to cause scars in different parts of the uterus. During the subsequent pregnancy, the incidence rate of cesarean scar pregnancy, placenta previa, placenta increta and the risk of termination of the first and mid-trimester pregnancy is likely to increase. Cesarean scar pregnancy is regarded as a risk factor of uterine rupture in the third trimester of pregnancy or delivery period, which severely affects the maternal and perinatal health and safety. This study is planning to prospectively include pregnant women aged 20-49 years from Peking University Third Hospital. All women with diagnosis on cesarean scar pregnancy was included prior to 14 wks of gestation. We divided the women into three different groups: type I, type II and type III according to characteristics in gestation sac,uterine scar, bladder, the latter with potentially worse outcomes in term of maternal morbidity and mortality. Data including demographics, medical history, reproductive history, prenatal health care, gestational complications, and pregnancy and birth outcomes will be collected via electronic data capture system.

Interventions

None listed

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Female aged ≥ 20 years * Female with cesarean scar pregnancy * Less than 14 gestational weeks * Planning to receive prenatal healthcare and delivery service at the study hospital

Exclusion criteria

* Inability to provide informed consent * Women with mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Incidence of perinatal death42 days postpartumperinatal death
Incidence of spontaneous abortiondeliveryspontaneous abortion
Incidence of stillbirthdeliverystillbirth
Incidence of blood lossdeliveryblood loss
Incidence of postpartum hemorrhagedeliverypostpartum hemorrhage
Incidence of maternal transfusiondeliverymaternal transfusion

Secondary

MeasureTime frameDescription
The rate of repeated cesarean deliveryAt deliveryCesarean rate is defined as the number of cesarean delivery divided by the number of live births.
Maternal deathAt 24-28 weeksDeaths during pregnancy or less than 42 days after termination of pregnancy

Contacts

Primary ContactYangyu Zhao, MD
zhaoyangyu@bjmu.edu.cn13701118357

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026